Professor Jianlin Shi is a preeminent scientist and internationally recognized leader in advanced ceramics and functional nanomaterials research. He currently holds a professorship at the State Key Laboratory of High Performance Ceramics and Superfine Microstructure within the Shanghai Institute of Ceramics, Chinese Academy of Sciences. After earning his Bachelor's degree from Nanjing University of Technology in 1983, he completed his Ph.D. at the Shanghai Institute of Ceramics, Chinese Academy of Sciences in 1989, establishing his foundational expertise in materials processing science. His early career contributions to sintering theory of advanced ceramics laid the groundwork for his subsequent pioneering work in nanostructured materials that would transform multiple scientific domains.
Professor Shi's groundbreaking research has significantly advanced the field through his development of mesoporous materials and host-guest nanocomposites that have enabled revolutionary applications in catalysis and biomedicine. His recent establishment of the innovative research frontier of nanocatalytic medicine represents a paradigm shift in cancer treatment, utilizing non-toxic nanoparticles to initiate intratumoral in-situ catalytic chemical reactions for antitumor purposes. With more than 500 publications cited over 33,000 times and an exceptional H-index of 108, his scientific impact is substantial and far-reaching across materials science and biomedical engineering. His work on hierarchically micro-mesoporous zeolites for large molecule-involved catalytic applications has opened new pathways in industrial catalysis while his research on upconversion nanoparticles has created novel diagnostic and therapeutic approaches in biomedicine.
As a highly cited researcher recognized by Thomson Reuters in 2015-2017, Professor Shi has received numerous prestigious awards including the National Nature Science Award second class in 2011 and multiple first-class Municipal Science Awards from Shanghai. His leadership extends beyond his laboratory, influencing the direction of materials science research internationally through his extensive publication record and collaborative networks. Currently, his research group continues to push the boundaries of nanocatalytic medicine while expanding into new areas of functional nanomaterials with biomedical applications. Professor Shi remains at the forefront of materials innovation, guiding his team toward developing next-generation nanotherapeutic platforms that promise to transform cancer treatment paradigms through catalytic approaches.
